Dawn Clawson Meyerriecks - 13 Feb 2026 Form 4 Insider Report for Churchill Capital Corp X/Cayman (CCCX)

Role
Director
Signature
/s/ Jason D. Hall, Attorney-in-Fact
Issuer symbol
CCCX
Transactions as of
13 Feb 2026
Net transactions value
$0
Form type
4
Filing time
18 Feb 2026, 08:55:22 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Meyerriecks Dawn Clawson Director C/O INFLEQTION, INC., 1315 WEST CENTURY DRIVE, SUITE 150, LOUISVILLE /s/ Jason D. Hall, Attorney-in-Fact 18 Feb 2026 0002108451

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CCCX Stock Option (Right to Buy) Award +347,403 347,403 13 Feb 2026 Common Stock 347,403 $0.6700 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Received pursuant to the Agreement and Plan of Merger and Reorganization, dated as of September 8, 2025, by and among Churchill Capital Corp X, a Delaware corporation now known as Infleqtion, Inc. ("Acquiror"), AH Merger Sub I, Inc., a direct, wholly-owned Subsidiary of Acquiror ("Merger Sub I"), AH Merger Sub II, LLC, a direct, wholly-owned Subsidiary of Acquiror ("Merger Sub II" and together with Merger Sub I, "Merger Subs") and ColdQuanta, Inc. (the "Company") pursuant to which (a) Merger Sub I was merged with and into the Company, and the Company continued as the surviving corporation and immediately thereafter, (b) the Company merged with and into Merger Sub II, and Merger Sub II became the surviving company and continued in existence as a wholly-owned subsidiary of Acquiror (collectively, the "Mergers"). In connection with the Mergers, Acquiror changed its name to Infleqtion, Inc. (the "Issuer").
F2 Fully vested.
F3 Pursuant to the Mergers, the legacy stock options of the Company were automatically converted into the right to receive stock options of the Issuer with the same terms and condition.